EACVI appropriateness criteria for the use of transthoracic echocardiography in adults: a report of literature and current practice review.
The European Association for Cardiovascular Imaging (EACVI) has outlined the rationale for setting appropriate use criteria (AUC) in cardiovascular (CV) imaging. Transthoracic echocardiography (TTE) is the most common imaging modality in CV disease and is a central tool in diagnosis, follow-up, management planning and intervention. The purpose of AUC is to inform referrers, both to avoid under-use, which may result in incomplete or incorrect diagnosis and treatment, and also over-use, which may delay correct diagnosis, lead to 'treatment cascade', and wastes resources. The first step in defining AUC for TTE in the adult has been for a panel of experts in echocardiography to review the evidence, guidelines, recommendations, and position papers from the European Society of Cardiology, EACVI and other specialist societies, and current state-of-the-art clinical practice. The attached document summarizes this work, which will be used to under-pin the development of AUC.
University Hospital Birmingham NHS Foundation Trust, Mindelsohn Road, Edgbaston, Birmingham, UK B15 2GW and Institute of Cardiovascular Sciences, University of Birmingham; UK.
Richard P
RP
Steeds
King's College Hospital NHS Foundation Trust, Denmark Hill, London, SE5 9RS UK.
Madalina
M
Garbi
Echocardiography Laboratory, Hospital da Luz Av. Lus?, n° 100 - 1500-650, Lisbon, Portugal.
Nuno
N
Cardim
Department of Cardiology, Bieganski Hospital Medical University of Lodz, Kniaziewicza 1/5, 91-347, Lodz, Poland.
Jaroslaw D
JD
Kasprzak
Department of Cardiology, Baskent University School of Medicine, Fevzi okmak Cad. 10. Sok. Bahcelievler 06490 Ankara, Turkey.
Elif
E
Sade
Imperial College London, NHLI Hammersmith Hospital, Du Cane Road, London W12 0NN, UK and University of Athens, Greece.
Petros
P
Nihoyannopoulos
University of Medicine and Pharmacy "Carol Davila"-Euroecolab, Institute of Cardiovascular Diseases, Sos. Fundeni 258, sector 2, 022328, Bucharest, Romania.
Bogdan Alexandru
BA
Popescu
1st Department of Cardiology, General Hospital of Nikea, 3 P. Mela str., 184 54, Athens, Greece.
Alexandros
A
Stefanidis
Department of Cardiology, CHVZ (Centrum voor Hart en Vaatziekten) Universitair Ziekenhuis, VUB, Laarbeeklaan 101, 1090 Jette, Brussel, Belgium.
Bernard
B
Cosyns
King's College Hospital NHS Foundation Trust, Denmark Hill, London, SE5 9RS UK.
Mark
M
Monaghan
Department of Cardiology, Oslo University Hospital, postboks 4950 Nydalen, 0424 Oslo and Faculty of Medicine, Norwegian University of Science and Technology, NTNU, 7491 Trondheim.
Svend
S
Aakhus
Department of Cardiology, Oslo University Hospital, Rikshospitalet, Sognsvannsveien 20, NO-0027 Oslo , Norway.
Thor
T
Edvardsen
Department of Medical Sciences, Clinical Physiology, Uppsala University, Akademiska ingang 40, 751 85 Uppsala, Sweden.
Frank
F
Flachskampf
Department of Cardiovascular Sciences, Catholic University of the Sacred Heart, Policlinico Agostino Gemelli, Largo A Gemelli 8, 00168 Roma, Italy.
Leonarda
L
Galiuto
Cardiology Section, Onassis Cardiac Surgery Center, Sygrou, 17674, Athens, Greece.
George
G
Athanassopoulos
Departments of Cardiology, University of Lie`ge Hospital, GIGA Cardiovascular Sciences, Heart Valve Clinic, CHU Sart Tilman, Lie'ge, Belgium and Gruppo Villa Maria Care and Research, Anthea, Hospital, Bari, Italy.
Patrizio
P
Lancellotti
D000328:Adult; D002318:Cardiovascular Diseases / Q000000981:diagnostic imaging*; D004452:Echocardiography / Q000592:standards* / Q000706:statistics & numerical data*; D005060:Europe; D019983:Guideline Adherence; D006300:Health Services Misuse; D006801:Humans
appropriateness; indications; transthoracic echocardiography